The Danish pharmaceutical company behind the high-profile drug Ozempic is set to invest $4.1 billion to develop a massive fill and manufacturing plant in Clayton, North Carolina, as the company continues to plot its expansion in what is being touted as the largest life science investment in the state's history.
Ozempic Maker Plans Record Investment for New North Carolina Plant
Novo Nordisk's $4.1 Billion Project Represents Largest Life Science Investment in State's History
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In